EMMPRIN is also highly expressed in a variety of tumors and the over-expression of EMMPRIN is associated with poor prognosis in cancer patients [2–7], suggesting that EMMPRIN may be an important factor that contributes to malignant tumor progression. Here, BSG is linked to cancer.